<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218306</url>
  </required_header>
  <id_info>
    <org_study_id>SPI_3417</org_study_id>
    <nct_id>NCT03218306</nct_id>
  </id_info>
  <brief_title>Surgical Pleth Index (SPI) Versus Standard Clinical Approach Analgesia</brief_title>
  <acronym>SPIDER</acronym>
  <official_title>Surgical Pleth Index Guided Intraoperative Analgesia Versus Standard Clinical Approach During Desflurane Based General Anesthesia for Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cagliari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cagliari</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is aimed at confronting a surgical pleth index based protocol for intraoperative
      analgesia in a desflurane based general anesthesia for thyroidectomy, versus a standard
      clinical approach. A reduction in analgesic consumption and improvement in hemodynamics are
      expected.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remifentanil consumption</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Cumulative remifentanil consumption throughout surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>intraoperative</time_frame>
    <description>Cumulative number of episodes of hypotension or hypertension or brady/tachycardia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Desflurane</measure>
    <time_frame>intraoperative</time_frame>
    <description>Cumulative consumption of desflurane (ml) as measured by datex ohmeda aysis ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation delay</measure>
    <time_frame>intraoperative</time_frame>
    <description>Timespan between end of surgery and extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative analgesia 1</measure>
    <time_frame>24 hr post operative</time_frame>
    <description>Evaluate the total consumption of analgesics in the first 24 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative analgesia 2</measure>
    <time_frame>24 hr post operative</time_frame>
    <description>measure pain in the first post-operative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse reactions</measure>
    <time_frame>24 hr post operative</time_frame>
    <description>Nausea and vomiting in the 1st post-operative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>24 hr post operative</time_frame>
    <description>Evaluate on a 0-4 numeric scale patient satisfaction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>SPI guided analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SPI â‰¤ 10 percentual points over the post-induction/pre-surgical incision value</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical Guided Analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No SPI guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgical Pleth Index</intervention_name>
    <description>Effector site concentration of remifentanil based on SPI</description>
    <arm_group_label>SPI guided analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical guidance</intervention_name>
    <description>Effector site concentration of remifentanil based on hemodynamic data</description>
    <arm_group_label>Clinical Guided Analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18&lt;age&lt;80 years

          -  American society of anesthesiology (ASA) physical status I -II

          -  6 hrs fasting

        Exclusion Criteria:

          -  Arrhythmia or Pacemaker

          -  Central or peripheral nervous system or muscular disease

          -  Drugs active on autonomous nervous system (eg clonidine)

          -  Obesity (BMI &gt;35)

          -  Chronic Pain

          -  Addictions or central nervous acting drugs use

          -  Hypertension (if not treated)

          -  Connective tissue disease

          -  Pregnancy

          -  Allergy or hypersensitivity to study drugs

          -  QT prolongation

          -  Absence of inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriele Finco, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Cagliari</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paolo Onida, MD</last_name>
    <phone>+3907051096543</phone>
    <email>paolo.onida80@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paolo Mura, MD</last_name>
    <phone>+3907051096543</phone>
    <email>mura_paolo@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Policlinico Duilio Casula</name>
      <address>
        <city>Monserrato</city>
        <state>Cagliari</state>
        <zip>09072</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Mura, MD</last_name>
      <phone>+39 3476527512</phone>
      <email>mura_paolo@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Paolo Onida, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paolo Mura, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tiziana Cabras, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Riccardo Pili, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cagliari</investigator_affiliation>
    <investigator_full_name>Prof. Gabriele Finco</investigator_full_name>
    <investigator_title>Professor of Anesthesiology and Intensive Care</investigator_title>
  </responsible_party>
  <keyword>SPI</keyword>
  <keyword>Remifentanil</keyword>
  <keyword>Target controlled infusion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

